SNYNF - Sanofi Non-GAAP EPS of Euro1.66 revenue of Euro10.92B; initiates FY24 outlook February, 01 2024 01:38 AM Sanofi 2024-02-01 01:38:24 ET More on Sanofi Sanofi Expands Rare Disease Focus With Inhibrx's INBRX-101 Acquisition Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 Sanofi to acquire Inhibrx rare disease asset in $2.2B deal Sanofi on track to snap its six-day win streak For further details see: Sanofi Non-GAAP EPS of €1.66, revenue of €10.92B; initiates FY24 outlook